Jump to the top of the page

William Blair Thinking

  • The A, B, C, and Ds of Medicare

    Medicare Open Enrollment closes on December 7, 2024. Review important considerations, as highlighted in an earlier Medicare presentation with Chapter.

    Read more
  • Exit Strategy: Preparing Yourself

    Preparing yourself and your family can be one of the most overlooked parts of an exit strategy. But it goes beyond maximizing tax efficiency and unlocking newfound wealth—it’s a monumental transition filled with emotional considerations.

    Read more
  • Decoding the Fourth Law of Thermodynamics and Its Impact on the Economy

    Jed Dorsheimer sits down with Andy Lees, founding partner of MacroStrategy Partnership, to explore the critical role of energy in our economy, touching on topics from renewables to inflation and the upcoming U.S. elections, and diving deep into the ways in which energy systems, economic growth, and social hierarchy intersect.

    Listen to the podcast

Our Mission, Vision, and Values

At William Blair, we're committed to our colleagues, our clients, and our communities. Serving our clients starts with the capabilities and collaboration of our team—making our employees our most important asset. When we create an environment where employees perform their best, our delivery for clients will be the best it can be.

Learn more about our mission, vision, and values

Global Community Partners

We are proud of our signature Global Community Partners program, through which employees nominate organizations to receive catalytic financial support and significant volunteerism opportunities every two years.

More about our community partners

Our Latest News

  • Mobilexpense Has Been Acquired by Visma

    William Blair acted as the exclusive financial advisor to Mobilexpense, a portfolio company of Fortino Capital, in connection with its sale to Visma.

    Read more
  • CARGO Therapeutics, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Cargo Therapeutics, Inc. (CRGX $16.23), a clinical-stage biotech company focused on developing next-generation CAR-T therapies for the treatment of cancer.

    Read more
  • Nasdaq, Inc.: Initiation of Research Coverage

    William Blair initiated research coverage of Nasdaq, Inc. (NDAQ $80.88), a leading global technology company with a broad range of offerings, including equities and options exchanges, data, investment analytics, software, marketplace technology, and corporate solutions.

    Read more

Join Our Team

Finding, attracting, and developing talented people is the foundation of our success. Learn about the promising career opportunities currently available at William Blair.

Search our job openings
Women sitting outside with a laptop

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures